| MeSH term | MeSH ID | Detail |
|---|---|---|
| Otitis Media | D010033 | 12 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
| DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
| Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |
| Abernathy CO et al. | Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note. | 1980 | Mech. Ageing Dev. | pmid:7354660 |
| Trujillo H | Cefadroxil monohydrate versus erythromycin in paediatric patients. | 1981 | J. Int. Med. Res. | pmid:7227625 |
| Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
| Simmen HP et al. | [Erythromycin]. | 1982 | Dtsch. Med. Wochenschr. | pmid:7117164 |
| Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
| Selenke WM et al. | Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects. | 1980 | J. Allergy Clin. Immunol. | pmid:6966289 |
| Ginsburg CM et al. | Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. | 1982 Nov-Dec | Pediatr Infect Dis | pmid:6761656 |